Key points are not available for this paper at this time.
Lupus nephritis (LN) is a prevalent and severe systemic lupus erythematosus (SLE) complication, affects 40-70% of patients, leading to increased morbidity and mortality. Identifying prognostic markers and understanding treatment response are critical. The objective of this study was to evaluate the response to immunosuppressive treatment in LN patients, assess proteinuria, complement levels of C3 and C4 at the third, sixth, and twelfth months of therapy, and correlate these findings.
Holanda et al. (Mon,) studied this question.